 After inclusion and baseline screening a group of healthy men with a normal office blood pressure will be randomized to either 4 weeks treatment with the drug Kaleorid, 750mg, 3 tablets 3 times daily or to 4 weeks treatment with placebo tablets, 3 tablets 3 times daily. 